Global Psychedelic therapeutics market is projected to grow at an annualized rate of ~15%- Roots Analysis'

Your avatar
Your avatar


Roots Analysis has done a detailed study on Global Psychedelic Therapeutics Market, 2020-2030” covering key aspects of the industry and identifying potential future growth opportunities



To order this 250+ page report, which features 120+ figures and 135+ tables, please visit this-


Key Market Insights

Nearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybin

The pipeline features product candidates based on a variety of psychedelic drug classes, which are being investigated for a wide range of target disease indications, and having different routes of administration

From a global perspective, this industry is anticipated to evolve significantly over the next few years as federal / regional regulators in different nations are gradually convinced of the clinical significance of this product class

Several organizations, having realized the untapped opportunity within this emerging segment of psychedelic therapeutics, have awarded grants of over USD 275 million across 500+ instances between 2015-2020

Several trials evaluating various psychedelic compounds against a wide range of therapeutic indication have been registered in the recent past

The growing interest is also reflected in the partnership activity since 2017; a number of different types of deals involving various drug classes have been established across multiple geographies

Presently, North American companies are actively consolidating their indigenous presence through strategic acquisitions; key value drivers behind such deals include both portfolio and geographical expansion

A number of eminent scientists from renowned universities have emerged as key opinion leaders in this domain, owing to their active involvement in clinical development efforts related to interventions based on psychedelics

Future market size, based on revenue reported from the sales of marketed and late stage psychedelic-based  therapies, is anticipated to be distributed across different therapeutic areas and key geographical regions


For more information, please visit


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

Cheer up, leave your comment
If you liked this post, you may also be interested in...
© 2021, Mamby Investments
Information Work with us Contact FAQs Creators Terms and Conditions